Literature DB >> 30682677

Challenges on the road to recovery: Exploring attitudes and experiences of clients in a community-based buprenorphine program in Baltimore City.

C Truong1, N Krawczyk2, M Dejman3, S Marshall-Shah4, K Tormohlen5, D Agus6, J Bass7.   

Abstract

OBJECTIVE: This qualitative study identifies and describes experiences and challenges to retention of individuals with opioid use disorder (OUD) who participated in a low-threshold combined buprenorphine-peer support treatment program in Baltimore.
METHODS: In-depth semi-structured interviews with staff and former clients of the Project Connections Buprenorphine Program (PCBP) (9 people) and focus group discussions with current and previous clients of PCBP (7 people) were conducted. Content analysis was used to extract themes regarding barriers to enrolling and remaining in, and transitioning from the program.
RESULTS: Primary challenges identified by the participants included struggles with cravings and symptoms of withdrawal, comorbid mental health issues, criminal justice system involvement, medication stigma, and conflicts over level of flexibility regarding program requirements and the role of employment.
CONCLUSIONS: This study identified several obstacles clients face when seeking care through a combined buprenorphine-peer support model. Findings highlight potential programmatic factors that can be improved and additional resources that may support treatment retention rates and better outcomes. Despite challenges, low-threshold and community-based programs can increase access to effective maintenance treatment for OUD, especially among vulnerable populations who may not have access to formal health services.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Buprenorphine; Community-based treatment; Low threshold treatment; Medication assisted treatment; Opioid use disorder; Peer support

Mesh:

Substances:

Year:  2019        PMID: 30682677      PMCID: PMC6528177          DOI: 10.1016/j.addbeh.2019.01.020

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  39 in total

1.  Release from prison--a high risk of death for former inmates.

Authors:  Ingrid A Binswanger; Marc F Stern; Richard A Deyo; Patrick J Heagerty; Allen Cheadle; Joann G Elmore; Thomas D Koepsell
Journal:  N Engl J Med       Date:  2007-01-11       Impact factor: 91.245

2.  Racial and ethnic differences in opioid agonist treatment for opioid use disorder in a U.S. national sample.

Authors:  Noa Krawczyk; Kenneth A Feder; Michael I Fingerhood; Brendan Saloner
Journal:  Drug Alcohol Depend       Date:  2017-07-11       Impact factor: 4.492

3.  A novel community-based buprenorphine program: client description and initial outcomes.

Authors:  Amy M Daniels; Elizabeth Salisbury-Afshar; Adam Hoffberg; Deborah Agus; Michael I Fingerhood
Journal:  J Addict Med       Date:  2014 Jan-Feb       Impact factor: 3.702

4.  Linking patients with buprenorphine treatment in primary care: Predictors of engagement.

Authors:  Claire B Simon; Judith I Tsui; Joseph O Merrill; Addy Adwell; Elsa Tamru; Jared W Klein
Journal:  Drug Alcohol Depend       Date:  2017-10-10       Impact factor: 4.492

5.  Leveraging Behavioral Health Expertise: Practices and Potential of the Project ECHO Approach to Virtually Integrating Care in Underserved Areas.

Authors:  Brant Hager; Michael Hasselberg; Eric Arzubi; Jonathan Betlinski; Mark Duncan; Jennifer Richman; Lori E Raney
Journal:  Psychiatr Serv       Date:  2018-02-15       Impact factor: 3.084

6.  Employment-based reinforcement of adherence to depot naltrexone in unemployed opioid-dependent adults: a randomized controlled trial.

Authors:  Jeffrey J Everly; Anthony DeFulio; Mikhail N Koffarnus; Jeannie-Marie S Leoutsakos; Wendy D Donlin; Will M Aklin; Annie Umbricht; Michael Fingerhood; George E Bigelow; Kenneth Silverman
Journal:  Addiction       Date:  2011-05-03       Impact factor: 6.526

7.  A meta-analysis comparing buprenorphine to methadone for treatment of opiate dependence.

Authors:  P G Barnett; J H Rodgers; D A Bloch
Journal:  Addiction       Date:  2001-05       Impact factor: 6.526

8.  Incarceration associated with homelessness, mental disorder, and co-occurring substance abuse.

Authors:  Dale E McNiel; Renée L Binder; Jo C Robinson
Journal:  Psychiatr Serv       Date:  2005-07       Impact factor: 3.084

9.  The Economic Burden of Prescription Opioid Overdose, Abuse, and Dependence in the United States, 2013.

Authors:  Curtis S Florence; Chao Zhou; Feijun Luo; Likang Xu
Journal:  Med Care       Date:  2016-10       Impact factor: 2.983

10.  The impact of low-threshold methadone maintenance treatment on mortality in a Canadian setting.

Authors:  Seonaid Nolan; Kanna Hayashi; M-J Milloy; Thomas Kerr; Huiru Dong; Viviane Dias Lima; Leslie Lappalainen; Julio Montaner; Evan Wood
Journal:  Drug Alcohol Depend       Date:  2015-09-28       Impact factor: 4.492

View more
  5 in total

1.  Opioid agonist treatment and fatal overdose risk in a state-wide US population receiving opioid use disorder services.

Authors:  Noa Krawczyk; Ramin Mojtabai; Elizabeth A Stuart; Michael Fingerhood; Deborah Agus; B Casey Lyons; Jonathan P Weiner; Brendan Saloner
Journal:  Addiction       Date:  2020-02-24       Impact factor: 6.526

2.  Robustness of estimated access to opioid use disorder treatment providers in rural vs. urban areas of the United States.

Authors:  Mathew V Kiang; Michael L Barnett; Sarah E Wakeman; Keith Humphreys; Alexander C Tsai
Journal:  Drug Alcohol Depend       Date:  2021-09-24       Impact factor: 4.492

3.  Human Rights, Stigma, and Substance Use.

Authors:  Jenifer Wogen; Maria Teresa Restrepo
Journal:  Health Hum Rights       Date:  2020-06

4.  The Genomics of Opioid Addiction Longitudinal Study (GOALS): study design for a prospective evaluation of genetic and non-genetic factors for development of and recovery from opioid use disorder.

Authors:  Jessica Heil; Stefan Zajic; Emily Albertson; Andrew Brangan; Iris Jones; Wendy Roberts; Michael Sabia; Elliot Bodofsky; Alissa Resch; Rachel Rafeq; Rachel Haroz; Russell Buono; Thomas N Ferraro; Laura Scheinfeldt; Matthew Salzman; Kaitlan Baston
Journal:  BMC Med Genomics       Date:  2021-01-07       Impact factor: 3.063

5.  Who stays in medication treatment for opioid use disorder? A national study of outpatient specialty treatment settings.

Authors:  Noa Krawczyk; Arthur Robin Williams; Brendan Saloner; Magdalena Cerdá
Journal:  J Subst Abuse Treat       Date:  2021-02-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.